Skip to content

Clinical Evaluation of Orion Lamina Cover in Patients Undergoing Lumbar Laminectomy With Instrumented Fusion

Clinical Evaluation of Orion Lamina Cover in Patients Undergoing Lumbar Laminectomy With Instrumented Fusion

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06532968
Enrollment
30
Registered
2024-08-01
Start date
2022-03-30
Completion date
2024-05-22
Last updated
2024-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Lumbar Spinal Stenosis, Degenerative Spondylolisthesis, Scoliosis, Spinal Fracture, Spinal Stenosis

Brief summary

Laminectomy with internal fixation and osseofusion is a common surgery for treating degenerative spinal diseases. It removes excessive bone spurs and removes the lamina for decompression to relieve nerve compression, and then utilizes a spinal fixation system to stabilize the structure to relieve lower limb pain, paralysis, and other symptoms. However, the spinal cord that lacks lamina coverage after surgery is often compressed by scar tissue formation and hematoma, leading to postoperative back and lower limb pain. Therefore, this trial is divided into two groups, comparing the use of the cross connector of the ORION spinal system - the spinal lamina cover and the general spinal fixation system (without lamina cover). For participants undergoing laminectomy with internal fixation and osseofusion, after utilizing the spinal lamina cover of the ORION spinal system, whether the nerve compression caused by postoperative scar tissue formation and hematoma can be effectively reduced, and the pain in the back and lower limbs can be improved.

Interventions

DEVICESham

Sham

DEVICEORION spinal lamina cover

an artificial lamina coverage of the ORION spinal system

Sponsors

Taipei Veterans General Hospital, Taiwan
CollaboratorOTHER_GOV
Orion Biotech Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Gender and age: females and males are at least 20 years old * Who with degenerative lumbar spondylolisthesis in one or two consecutive segments from lumbar vertebra L1 to sacral vertebra S1, and have objective evidence of back pain and numbness radiating to the lower limbs. * Clinical symptoms of degenerative lumbar spondylolisthesis, accompanied by objective symptoms of neurological deficit; spinal stenosis, neurogenic claudication or bilateral radiating pain. * Have received at least 3 months of non-surgical treatment without effectiveness. * Radiographic examination was consistent with clinical symptoms of degenerative spondylolisthesis or spinal stenosis. * After diagnosis who needs laminectomy with internal fixation and osseofusion * Able and willing to sign the consent form and answer the questionnaire.

Exclusion criteria

* Already had lumbar surgery at the same lumbar vertebra * Physically health not well * Probably pregnant * Who suffering from malignant tumors or infections * below 20 years old * Unable and unwilling to answer the questionnaire and return to the hospital for treatment * Unable to undergo MRI examination due to any reason, such as having a cardiac rhythm regulator, ferromagnetic implants, or claustrophobia.

Design outcomes

Primary

MeasureTime frameDescription
Magnetic Resonance Imaging (MRI)Six months after surgeryTo observe the recovery of the participants' spine
Visual Analogue Scale (VAS)Pre-surgery; one month after surgery; three months after surgery; six months after surgeryTo measure the pain and numb of the participants' back and limbs

Secondary

MeasureTime frameDescription
Oswestry Disability Index (ODI)Pre-surgery; one month after surgery; three months after surgery; six months after surgeryTo evaluate the functional disability of the participants' limbs
Sort Form-12 Health Survey (SF-12)Pre-surgery; one month after surgery; three months after surgery; six months after surgeryTo evaluate the physical health of the participants

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026